European Union Trade Commissioner Peter Mandelson has warned the Thai government against moves that would force drugmakers to drop their prices on expensive medication, the Financial Times reported on Friday.
In a letter seen by the business daily, Mandelson wrote that Thailand "may be taking a new approach to medicines," adding that the country's military government "stated that if drug companies wish to do business in Thailand, they should offer their drugs for no more than five percent above the generic cost."
Drug Patent Compulsory Licensing
Ambiguous international rules outlining when and how governments may "break" pharmaceutical patents may end up significantly reducing incentives for innovation.
Advertisement
"This approach is a matter of concern for the European Union and would be detrimental to the patent system, and so to innovation and the development of new medicines."
Thailand has clashed with Western governments in the past over threats to extend the use of compulsory licenses, which are allowed under World Trade Organisation (WTO) rules so that countries can temporarily suspend patent protections on medicines that safeguard public health.
Mandelson also reportedly wrote that Thailand's moves would be in breach of WTO regulations, and encouraged Bangkok to negotiate with drugmakers.
According to the FT, Thailand has yet to reply to the letter, which was written in July.
Source: AFP
LIN/J
Mandelson also reportedly wrote that Thailand's moves would be in breach of WTO regulations, and encouraged Bangkok to negotiate with drugmakers.
According to the FT, Thailand has yet to reply to the letter, which was written in July.
Source: AFP
LIN/J
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Drug News
New discoveries about aspirin's interplay between messenger molecules that are crucial in the inflammatory proves again that it is a powerful anti-inflammatory drug.
The new drug target sheds insights into strategies to fight drug-resistant S. pneumoniae, stated research.
The effectiveness of adding fludrocortisone to hydrocortisone vs hydrocortisone alone among patients with septic shock was analyzed using target trial emulation.
Safety and effectiveness of commonly used painkillers (analgesics) for short-term relief of low back pain remain uncertain.
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.